Avacta Group PLC (AVCT)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
76.00p
Buy
78.00p
0.10p (+0.13%)
Prices updated at 12 Dec 2025, 17:07 GMT
| Prices minimum 15 mins delay
Prices in GBX
Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 100.00 |
| 2023 | 99.47 |
| 2022 | 75.03 |
| 2021 | 68.58 |
| 2020 | 55.13 |
| 2019 | 78.05 |
| 2018 | 67.68 |
| 2017 | 65.59 |
| 2016 | 58.66 |
| 2015 | 70.99 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 2,533.16 |
| 2024 | 6.67 |
| 2023 | 19.22 |
| 2022 | 41.50 |
| 2021 | 78.20 |
| 2020 | 30.55 |
| 2019 | 4.62 |
| 2018 | 7.22 |
| 2017 | 16.00 |
| 2016 | 22.52 |
| 2015 | 36.89 |
Price/Forward earnings (YTD)
-14.31
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -87.01 |
| 2023 | -40.04 |
| 2022 | -52.36 |
| 2021 | -45.98 |
| 2020 | -39.41 |
| 2019 | -39.38 |
| 2018 | -32.10 |
| 2017 | -18.43 |
| 2016 | -15.76 |
| 2015 | -38.10 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 5.20 |
| 2023 | 4.33 |
| 2022 | 4.43 |
| 2021 | 1.14 |
| 2020 | 1.09 |
| 2019 | - |
| 2018 | 1.10 |
| 2017 | 1.06 |
| 2016 | 1.05 |
| 2015 | 1.12 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
